ARTICLE | Company News
EC approves Victrelis
July 19, 2011 12:22 AM UTC
The European Commission approved an MAA from Merck & Co. Inc. (NYSE:MRK) for Victrelis boceprevir to treat chronic HCV genotype 1 infection in combination with standard of care -- peginterferon alfa a...